1 Service de Néphrologie-Immunologie Clinique, CHU Tours, Tours, France.
2 FCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, François-Rabelais University, Tours, France.
3 Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
4 Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
5 Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece.
6 Service of Nephrology and Hypertension, University Hospital (CHUV), Lausanne, Switzerland.
7 Antwerp University Hospital, Department of Nephrology, and Antwerp University, Belgium.
8 Departement of Nephrology, Medical University of Vienna, Austria.
9 CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy.
10 FCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, Manhes Hospital and FCRIN INI-CRCTC, Manhes, France.
11 INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, Université de Lorraine, CHU de Nancy, and FCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, Vandoeuvre-lès-Nancy, France.